ChromaDex Reports Second Quarter Ingredient Sales Grew 155% Year-Over-Year and 52% Sequentially
date:Aug 13, 2014
cs (PK) and bioavailability of NR as well as provide information about an effective dose range in humans. Most importantly, this study aims to confirm earlier animal studies conducted by various universities and research institutes, which showed that oral dosing of the compound results in an increased level of nicotinamide adenine dinucleotide (NAD+) and NAD+ metabolites in the body.
12/12 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/14 20:08